comparemela.com

Latest Breaking News On - Therapeutics inc - Page 1 : comparemela.com

Appili Therapeutics Inc (OTCMKTS:APLIF) Short Interest Down 28 4% in May

Appili Therapeutics Inc. (OTCMKTS:APLIF – Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 28,300 shares, a decrease of 28.4% from the May 15th total of 39,500 shares. Based on an average daily volume of 138,600 shares, […]

Short Interest in HLS Therapeutics Inc (OTCMKTS:HLTRF) Drops By 79 4%

HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 700 shares, a decline of 79.4% from the May 15th total of 3,400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover […]

Denali Therapeutics (NASDAQ:DNLI) Sees Large Volume Increase

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) shares saw strong trading volume on Wednesday . 2,015,233 shares traded hands during trading, an increase of 76% from the previous session’s volume of 1,148,126 shares.The stock last traded at $22.39 and had previously closed at $21.60. Wall Street Analyst Weigh In A number of equities research […]

Artia Global Partners LP Makes New Investment in RAPT Therapeutics, Inc (NASDAQ:RAPT)

Artia Global Partners LP purchased a new stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 19,638 shares of the company’s stock, valued at approximately $488,000. RAPT Therapeutics accounts for approximately 0.1% of […]

Applied Therapeutics, Inc (NASDAQ:APLT) CFO Sells $73,353 60 in Stock

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) CFO Leslie D. Funtleyder sold 16,980 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $4.32, for a total transaction of $73,353.60. Following the completion of the sale, the chief financial officer now owns 291,441 shares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.